231 filings
Page 4 of 12
6-K
nk1 8re48m73935
9 Jan 23
SciSparc Signs Agreement to Conduct its Clinical Trial in Autism Spectrum Disorder with Soroka Medical Center
4:01pm
6-K
bcm1syjmca hvm3ke
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
h9htss
14 Dec 22
SciSparc Enters Into Non-Binding Letter of Intent to Sell a 50% interest in its Subsidiary that Owns an Amazon Top Seller Brand
4:01pm
6-K
na9dfj5a
7 Dec 22
SciSparc Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy
1:08pm
6-K
au9 lj8mg2csqzd
29 Nov 22
Report of Foreign Private Issuer
12:27pm
6-K
1jk ltweo0a6
16 Nov 22
SciSparc Enters Into Letter of Intent with an E-commerce Company to Establish a Joint Venture to Market and Develop a New Product Line
4:02pm
6-K
ib86wibeiz
8 Nov 22
SciSparc Announced Positive Interim Results Meeting Primary Endpoints at Phase IIa Study in Alzheimer’s Disease Patients with Agitation
7:33am
6-K
3zlpadgyzl3k0elbz4z
1 Nov 22
Since launch the new product has had approximately 117% ROI
4:00pm
6-K
ewulaj228r123z
12 Oct 22
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
9:05am
6-K
gbfoab5jhjz1
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
24b38z97 j7424hf
16 Sep 22
Report of Foreign Private Issuer
11:03am
6-K
6oftux4h7p9sd2v4
25 Aug 22
Results indicate significant decrease in cocaine craving in a sub-group that received the treatment
6:54am
6-K
uoux0jwxug60ax2we
19 Aug 22
Scisparc Announces the Full Exercise of Pre-Funded Warrants
4:01pm
6-K
4az8h5q
16 Aug 22
SciSparc Signs a Non-Binding Letter of Intent to Acquire American Food Supplements and Cosmetics Brand in Approximately $20 Million Deal
6:30am
6-K
af0rs bkbkoanpuod8
12 Aug 22
SciSparc Issued Israeli Patent for its Core Technology for Treating Central Nervous Systems Disorders
4:05pm
6-K
e41ad rmmblp3khc
11 Aug 22
Current Report
4:05pm
6-K
ikuo4z
11 Aug 22
SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:42am
6-K
eic7f8h7tk4qaivt jzv
4 Aug 22
Report of Foreign Private Issuer
4:00pm
6-K
rualmc uy2jnp
2 Aug 22
SciSparc Signs Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome
4:00pm
6-K
f5v69michkm
7 Jul 22
Report of Foreign Private Issuer
4:00pm